Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.51% is 150% above its 5-year average of -7.07%, near the high end of its 5-year range (-21.12%–5.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 286.67% above its 12-month average of 0.91%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 3.51%.
RETURN ON EQUITY (ROE)
3.51%
RETURN ON EQUITY (ROE) AVG TTM
0.91%
RETURN ON EQUITY (ROE) AVG 3Y
-8.82%
RETURN ON EQUITY (ROE) AVG 5Y
-7.07%
RETURN ON EQUITY (ROE) AVG 10Y
-9.93%
RETURN ON EQUITY (ROE) AVG 15Y
-9.25%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+286.67%
CURRENT VS 3Y AVG
+139.79%
CURRENT VS 5Y AVG
+149.65%
CURRENT VS 10Y AVG
+135.36%
CURRENT VS 15Y AVG
+137.93%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.21%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
+108.73%
vs the sector median at left
OptimizeRx Corp.
Market Cap
$165.88M
Return on Equity (ROE)
3.51%
TTM Avg
0.91%
3Y Avg
-8.82%
5Y Avg
-7.07%
Market Cap
$164.64M
Return on Equity (ROE)
-51.90%
TTM Avg
-23.95%
3Y Avg
-20.95%
5Y Avg
-18.62%
Market Cap
$164.54M
Return on Equity (ROE)
-215.26%
TTM Avg
-150.35%
3Y Avg
8.65%
5Y Avg
-35.35%
Market Cap
$162.20M
Return on Equity (ROE)
-60.19%
TTM Avg
-68.34%
3Y Avg
-61.91%
5Y Avg
-47.91%
Market Cap
$169.85M
Return on Equity (ROE)
-31.32%
TTM Avg
4.38%
3Y Avg
4.09%
5Y Avg
11.26%
Market Cap
$170.85M
Return on Equity (ROE)
-56.61%
TTM Avg
-75.88%
3Y Avg
-88.15%
5Y Avg
-30.55%
Market Cap
$158.63M
Return on Equity (ROE)
N/A
TTM Avg
101.44%
3Y Avg
117.16%
5Y Avg
-25.56%
Market Cap
$155.86M
Return on Equity (ROE)
N/A
TTM Avg
13.51%
3Y Avg
15.58%
5Y Avg
15.05%
Market Cap
$173.23M
Return on Equity (ROE)
-54.27%
TTM Avg
-50.07%
3Y Avg
-62.91%
5Y Avg
-60.87%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $165.88M | 3.51% | 0.91% | -8.82% | -7.07% |
| Quanterix Corporation (QTRX)vs › | $164.64M | -51.90% | -23.95% | -20.95% | -18.62% |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | -215.26% | -150.35% | 8.65% | -35.35% |
| PepGen Inc. (PEPG)vs › | $162.20M | -60.19% | -68.34% | -61.91% | -47.91% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | -31.32% | 4.38% | 4.09% | 11.26% |
| MediWound Ltd. (MDWD)vs › | $170.85M | -56.61% | -75.88% | -88.15% | -30.55% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | N/A | 101.44% | 117.16% | -25.56% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | 13.51% | 15.58% | 15.05% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | -54.27% | -50.07% | -62.91% | -60.87% |
| Cue Biopharma, Inc. (CUE)vs › | $173.26M | -7104.24% | -166.54% | -137.65% | -112.46% |
ROE
3.5%
ROA
2.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 3.51% |
| 2026-03-31 | 5.27% |
| 2025-12-31 | 4.00% |
| 2025-09-30 | 0.03% |
| 2025-06-30 | -8.27% |
| 2025-03-31 | -13.25% |
| 2024-12-31 | -17.19% |
| 2024-09-30 | -21.12% |
| 2024-06-30 | -14.80% |
| 2024-03-31 | -14.74% |
| 2023-12-31 | -13.88% |
| 2023-09-30 | -11.84% |
| 2023-06-30 | -12.39% |
| 2023-03-31 | -11.35% |
| 2022-12-31 | -9.07% |
| 2022-09-30 | -8.10% |
| 2022-06-30 | -4.96% |
| 2022-03-31 | -2.10% |
| 2021-12-31 | 0.29% |
| 2021-09-30 | 0.88% |
| 2021-06-30 | 0.63% |
| 2021-03-31 | -0.53% |
| 2020-12-31 | -4.42% |
| 2020-09-30 | -11.89% |
| 2020-06-30 | -15.72% |
| 2020-03-31 | -12.27% |
| 2019-12-31 | -7.00% |
| 2019-09-30 | -3.08% |
| 2019-06-30 | 1.31% |
| 2019-03-31 | 2.17% |
| 2018-12-31 | 1.23% |
| 2018-09-30 | 0.58% |
| 2018-06-30 | -4.86% |
| 2018-03-31 | -20.64% |
| 2017-12-31 | -33.82% |
| 2017-09-30 | -36.68% |
| 2017-06-30 | -28.43% |
| 2017-03-31 | -29.32% |
| 2016-12-31 | -19.70% |
| 2016-09-30 | -19.91% |
| 2016-06-30 | -15.58% |
| 2016-03-31 | -9.78% |
| 2015-12-31 | -6.66% |
| 2015-09-30 | -1.14% |
| 2015-06-30 | -12.50% |
| 2015-03-31 | -10.56% |
| 2014-12-31 | -22.24% |
| 2014-09-30 | -23.58% |
| 2014-06-30 | -15.46% |
| 2014-03-31 | -7.23% |
| 2013-12-31 | 10.58% |
| 2013-09-30 | 18.35% |
| 2013-06-30 | 14.70% |
| 2013-03-31 | -12.09% |
| 2012-12-31 | -24.34% |
| 2012-09-30 | -73.96% |
| 2012-06-30 | -133.02% |
| 2012-03-31 | -156.66% |
| 2011-12-31 | -133.45% |
| 2011-09-30 | -103.95% |
| 2011-06-30 | -117.04% |
| 2011-03-31 | -116.92% |
| 2010-12-31 | -106.08% |
| 2010-09-30 | -278.58% |
| 2010-06-30 | -217.83% |
| 2010-03-31 | -558.03% |
| 2009-12-31 | -534.51% |
| 2009-09-30 | -496.56% |
| 2009-06-30 | -367.27% |
| 2009-03-31 | -306.87% |
| 2008-12-31 | -189.28% |
